On March 11, President Trump took a tour of a manufacturing facility in Reading, Ohio, owned by Thermo Fisher Scientific, a medical supply company. During the tour, Trump lavished praise on Thermo Fisher which uses the facility to manufacture prescription drugs on a contract basis. “It’s a great honor being here. It’s a great company,” Trump said, appearing alongside CEO Marc Casper. “You have done a fantastic job and I’d like to congratulate you.”

Later, Trump asked another Thermo Fisher executive to share “some great information about this incredible company.” The executive talked about how Thermo Fisher is producing drugs for Merck and others at the facility. Trump then explicitly encouraged other pharmaceutical companies to contract with Thermo Fisher to “on-shore” more jobs. He claimed that some pharmaceutical companies were building their own US manufacturing facilities but said “they can get here a lot faster by using this great company.”

Trump did not mention that, the same day of the tour, March 11, he purchased between $15,000 and $50,000 of Thermo Fisher stock. (Federal disclosure rules only require filers to list their transactions in broad ranges.) Trump did not publicly disclose the purchase until May 14. It was listed on page 38 of a 113-page document cataloging Trump’s stock purchases in 2026.